Atomoxetine Hydrochloride + Sertraline + Placebo

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
85
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Depressive Symptoms

Conditions

Depressive Symptoms

Trial Timeline

Jun 1, 2003 โ†’ Jan 1, 2005

About Atomoxetine Hydrochloride + Sertraline + Placebo

Atomoxetine Hydrochloride + Sertraline + Placebo is a approved stage product being developed by Eli Lilly for Depressive Symptoms. The current trial status is completed. This product is registered under clinical trial identifier NCT00485862. Target conditions include Depressive Symptoms.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00485862ApprovedCompleted

Competing Products

20 competing products in Depressive Symptoms

See all competitors
ProductCompanyStageHype Score
duloxetineEli LillyPre-clinical
23
Duloxetine HydrochlorideEli LillyPre-clinical
23
LY2216684Eli LillyPhase 1
33
LY2216684Eli LillyPhase 1
33
DuloxetineEli LillyPhase 3
77
LY2216684 + DigoxinEli LillyPhase 1
33
Duloxetine + ParoxetineEli LillyPhase 3
77
Duloxetine + placeboEli LillyPhase 3
77
LY2216684 + Placebo + EscitalopramEli LillyPhase 2
52
FK949EAstellas PharmaPhase 1
33
quetiapine extended release (XR) + PlaceboAstellas PharmaPhase 2
52
FK949EAstellas PharmaPhase 1
33
FK949EAstellas PharmaPhase 1
33
FK949EAstellas PharmaPhase 1
33
Mirtazapine TabletsSun PharmaceuticalApproved
85
Duloxetine HydrochlorideShionogiPhase 3
77
Duloxetine Hydrochloride + PlaceboShionogiPhase 3
77
ONO-2333Ms Experimental 2 + Placebo + ONO-2333Ms Experimental 1Ono PharmaceuticalPhase 2
52
ONO-1110 + PlaceboOno PharmaceuticalPhase 2
52
Pramipexole ER + EscitalopramCiplaPhase 2
52